Quick Answer
HAEMONETICS CORP reported Total Revenue of $903.92 million for fiscal year 2018.
HAEMONETICS CORP Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2018 | $903.92M | +2.0% |
| 2017 | $886.12M | -2.5% |
| 2016 | $908.83M | -0.2% |
| 2015 | $910.37M | -3.0% |
| 2014 | $938.51M | +5.2% |
| 2013 | $891.99M | +22.6% |
| 2012 | $727.84M | +7.6% |
| 2011 | $676.69M | +4.8% |
| 2010 | $645.43M | +8.0% |
| 2009 | $597.88M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $338.97M | -2.7% | +3.6% |
| September 30, 2025 | $327.31M | -5.3% | +1.8% |
| June 30, 2025 | $321.39M | -4.4% | -7.8% |
| December 31, 2024 | $348.54M | +3.7% | +0.9% |
| September 30, 2024 | $345.51M | +8.6% | +2.8% |
| June 30, 2024 | $336.17M | +8.0% | -0.0% |
| December 31, 2023 | $336.25M | +10.1% | +5.7% |
| September 30, 2023 | $318.18M | +7.0% | +2.2% |
- HAEMONETICS CORP showed an increase of +2.0% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2018 period, HAEMONETICS CORP’s total revenue has grown by 51.2% (from $597.88 million to $903.92 million).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2017 report (Form 10-K), filed with the SEC on May 23, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: